Gender-Affirming Facial Surgery: Experiences and Outcomes at an Academic Center.
Madeleine SaleskyAaron L ZebolskyTania BenjaminJacqueline A WuluAndrea ParkP Daniel KnottRahul SethPublished in: Facial plastic surgery & aesthetic medicine (2021)
Background: Gender-affirming facial surgery (GFS) is becoming more widely available for transgender individuals, but data on surgical approaches and outcomes remain limited. Methods: Retrospective analysis of surgical outcomes among consecutive GFS cases performed at a tertiary care academic center between March 2016 and August 2020. Results: Seventy-seven patients underwent 109 surgeries, including 478 individual procedures. The median age was 42 years. Ninety-five percent of patients had public health insurance. Two-stage GFS was often used in older patients (p = 0.001), with the first stage involving bone and cartilaginous alterations, and the second stage involving soft tissue procedures. Mean hospital stay after first-stage GFS was 1.2 days, with 70% discharged on postoperative day 1. Mean follow-up was 11.3 months. Among 66 patients with at least 1 month of follow-up, all complications were minor and included surgical site infection (5%), dehiscence (3.0%), seroma (3%), and medical complications (6%). Thirty-day hospital readmission rate was 1.5%. Conclusions: There are unique surgical approaches for GFS, which demonstrate low complication and readmission rates. Understanding these approaches and outcomes may help guide preoperative patient consultations and clinical decision making.
Keyphrases
- soft tissue
- end stage renal disease
- health insurance
- surgical site infection
- healthcare
- minimally invasive
- ejection fraction
- newly diagnosed
- mental health
- chronic kidney disease
- tertiary care
- patients undergoing
- decision making
- peritoneal dialysis
- risk factors
- prognostic factors
- emergency department
- case report
- postmenopausal women
- machine learning
- artificial intelligence
- electronic health record
- insulin resistance
- hepatitis c virus
- antiretroviral therapy
- general practice
- weight loss